Based on these diverse tumor-promoting functions and the breadth of tumor types in which FOXC2 is dysregulated, it is important to improve our understanding of this transcription factor's regulation of oncogenic pathways in cancer cells. This evidence concerns the gene FOXC2 and cancer.